| Product Code: ETC8272214 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Antiretroviral Therapy Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Antiretroviral Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Antiretroviral Therapy Market - Industry Life Cycle |
3.4 Mexico Antiretroviral Therapy Market - Porter's Five Forces |
3.5 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Antiretroviral Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Mexico |
4.2.2 Government initiatives to improve access to antiretroviral therapy |
4.2.3 Technological advancements in antiretroviral drugs |
4.3 Market Restraints |
4.3.1 High cost associated with antiretroviral therapy |
4.3.2 Stigma and discrimination against people living with HIV/AIDS |
4.3.3 Limited healthcare infrastructure in certain regions of Mexico |
5 Mexico Antiretroviral Therapy Market Trends |
6 Mexico Antiretroviral Therapy Market, By Types |
6.1 Mexico Antiretroviral Therapy Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By HIV Protease Inhibitors, 2021- 2031F |
6.1.5 Mexico Antiretroviral Therapy Market Revenues & Volume, By Non-nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.6 Mexico Antiretroviral Therapy Market Revenues & Volume, By Nucleotide Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.7 Mexico Antiretroviral Therapy Market Revenues & Volume, By HIV Fusion Inhibitors, 2021- 2031F |
6.1.8 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Antiretroviral Therapy Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Antiretroviral Therapy Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Antiretroviral Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Antiretroviral Therapy Market Import-Export Trade Statistics |
7.1 Mexico Antiretroviral Therapy Market Export to Major Countries |
7.2 Mexico Antiretroviral Therapy Market Imports from Major Countries |
8 Mexico Antiretroviral Therapy Market Key Performance Indicators |
8.1 Percentage of population with access to antiretroviral therapy |
8.2 Number of healthcare facilities offering antiretroviral treatment |
8.3 Research and development investment in new antiretroviral drugs |
9 Mexico Antiretroviral Therapy Market - Opportunity Assessment |
9.1 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Mexico Antiretroviral Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Antiretroviral Therapy Market - Competitive Landscape |
10.1 Mexico Antiretroviral Therapy Market Revenue Share, By Companies, 2024 |
10.2 Mexico Antiretroviral Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here